Entering text into the input field will update the search result below

Avadel surges 13% as Jefferies upgrades on opportunity to dent Jazz's market share

Nov. 30, 2022 11:32 AM ETAvadel Pharmaceuticals plc (AVDL), JAZZBy: Ravikash, SA News Editor2 Comments

Wall street sign in New York city financial economy and business district with America national flag background. Stock market trade and exchange zone.


Avadel Pharmaceuticals (NASDAQ:AVDL) stock rose ~13% on Wednesday after Jefferies Financial upgraded the shares to Buy from Hold on opportunity of taking market share from Jazz Pharmaceuticals' (NASDAQ:JAZZ) oxybate franchise.

The SA Quant Rating on AVDL is Hold, which is in contrast

Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Holding till it gains attention.
Oil And Gas Interest profile picture
@FranciscoAS It's coming. Keep holding. Appeals court decision today was major.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.